AU762126B2 - Method for treating hot flashes in humans - Google Patents

Method for treating hot flashes in humans Download PDF

Info

Publication number
AU762126B2
AU762126B2 AU59031/99A AU5903199A AU762126B2 AU 762126 B2 AU762126 B2 AU 762126B2 AU 59031/99 A AU59031/99 A AU 59031/99A AU 5903199 A AU5903199 A AU 5903199A AU 762126 B2 AU762126 B2 AU 762126B2
Authority
AU
Australia
Prior art keywords
human
alkyl
hydroxy
glycopyrrolate
glycopyrrolate analog
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU59031/99A
Other languages
English (en)
Other versions
AU5903199A (en
Inventor
Arthur M. Bobrove
Jeffrey D. Urman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/184,512 external-priority patent/US5962505A/en
Application filed by Individual filed Critical Individual
Publication of AU5903199A publication Critical patent/AU5903199A/en
Application granted granted Critical
Publication of AU762126B2 publication Critical patent/AU762126B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AU59031/99A 1998-08-31 1999-08-31 Method for treating hot flashes in humans Ceased AU762126B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US9862998P 1998-08-31 1998-08-31
US60/098629 1998-08-31
US09/184512 1998-11-02
US09/184,512 US5962505A (en) 1998-08-31 1998-11-02 Method for treating hot flashes in humans
US09/360,074 US6395757B1 (en) 1998-08-31 1999-07-23 Method for treating hot flashes in humans
US09/360074 1999-07-23
PCT/US1999/019693 WO2000012087A1 (en) 1998-08-31 1999-08-31 Method for treating hot flashes in humans

Publications (2)

Publication Number Publication Date
AU5903199A AU5903199A (en) 2000-03-21
AU762126B2 true AU762126B2 (en) 2003-06-19

Family

ID=27378636

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59031/99A Ceased AU762126B2 (en) 1998-08-31 1999-08-31 Method for treating hot flashes in humans

Country Status (7)

Country Link
US (1) US6395757B1 (enExample)
EP (1) EP1123098A4 (enExample)
JP (1) JP4601170B2 (enExample)
CN (1) CN1315860A (enExample)
AU (1) AU762126B2 (enExample)
CA (1) CA2339996C (enExample)
WO (1) WO2000012087A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10136404A1 (de) * 2001-07-26 2003-02-20 Johannes Wohlrab Arzneiformulierung zur topischen Anwendung für die Therapie und Prophylaxe von Hyperhidrosis
US20050288343A1 (en) * 2004-05-19 2005-12-29 Andrew Rusowicz Process of preparing substituted carbamates and intermediates thereof
US7915303B2 (en) * 2005-03-24 2011-03-29 Sosei R&D Ltd. Glycopyrronium salts and their therapeutic use
US20080260823A1 (en) * 2007-04-20 2008-10-23 Sciele Pharma, Inc. Orally disintegrating tablet comprising glycopyrrolate for treating sialorrhea
US8053004B2 (en) * 2007-10-08 2011-11-08 Starmaker Products, Llc Ointment for topical treatment of hot flashes and method of use
AU2013271442B2 (en) 2012-06-08 2017-10-05 The Ohio State University Treating burn and scar injury using tocotrienol
US9006462B2 (en) 2013-02-28 2015-04-14 Dermira, Inc. Glycopyrrolate salts
KR20150119468A (ko) 2013-02-28 2015-10-23 더미라, 인코포레이티드 글리코피롤레이트 염
US8558008B2 (en) 2013-02-28 2013-10-15 Dermira, Inc. Crystalline glycopyrrolate tosylate
WO2015028976A2 (en) * 2013-08-30 2015-03-05 Mahesh Kandula Compounds and methods for the treatment of inflammatory diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2956062A (en) 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
US3943242A (en) 1974-04-10 1976-03-09 American Cyanamid Company Deodorant composition containing a quaternary ammonium saccharinate salt
US4096254A (en) 1976-05-10 1978-06-20 Richardson-Merrell Inc. Method of treating the symptoms of menopause and osteoporosis
US4824676A (en) * 1984-10-11 1989-04-25 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
US5008111A (en) 1984-10-11 1991-04-16 Schering Corporation Physiological means of enhancing transdermal delivery of drugs
DE3583234D1 (de) * 1984-10-11 1991-07-18 Key Pharma Physiologische mittel zur steigerung der transdermalen freisetzung von arzneimitteln.
US5155045A (en) 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
US5223528A (en) 1986-03-17 1993-06-29 University Of Florida Anticholinergic compounds, composititons and methods of treatment
US5258388A (en) 1986-03-17 1993-11-02 University Of Florida Anticholinergic compounds, compositions and methods of treatment
US5462950A (en) 1993-12-21 1995-10-31 Eli Lilly And Company Methods of treating menstrual symptoms and compositions therefore
US5512555A (en) 1994-07-21 1996-04-30 Merck & Co., Inc. Method of treating sweat-related conditions using finasteride, epristeride and a cholestan-3-one
US5525347A (en) 1995-01-31 1996-06-11 Medical University Of South Carolina Composition and methods for treating performance anxiety
US5744463A (en) 1996-06-03 1998-04-28 Bair; Glenn O. Treatment of side effects of progestins and progesterone analogues used for birth control
US5962505A (en) * 1998-08-31 1999-10-05 Bobrove; Arthur M. Method for treating hot flashes in humans

Also Published As

Publication number Publication date
US6395757B1 (en) 2002-05-28
CA2339996C (en) 2009-06-16
CN1315860A (zh) 2001-10-03
WO2000012087A1 (en) 2000-03-09
JP4601170B2 (ja) 2010-12-22
EP1123098A1 (en) 2001-08-16
EP1123098A4 (en) 2002-01-02
AU5903199A (en) 2000-03-21
CA2339996A1 (en) 2000-03-09
JP2002523458A (ja) 2002-07-30

Similar Documents

Publication Publication Date Title
US5962505A (en) Method for treating hot flashes in humans
JP7008988B2 (ja) ソフト抗コリン作用性エステルの投与の方法および使用
US6433003B1 (en) Method for treating hyperhidrosis in mammals
JPH07504904A (ja) 皮膚の脂肪症処置剤
AU762126B2 (en) Method for treating hot flashes in humans
WO2005034890A2 (en) Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
CA1204059A (en) Spironolactone containing composition for combatting acne
JP6408489B2 (ja) 治療配合物（ｃｏｍｐｏｕｎｄｓ）
CA1254517A (fr) Compositions pharmaceutiques contenant comme ingredient actif la dihydroxy-1,8 phenyl-10 anthrone- 9
KR101733189B1 (ko) 손톱 또는 발톱 성장 촉진용 조성물
HK1256597A1 (zh) 含有细胞老化抑制剂作为有效成分的皮肤皱纹改善用及皮肤损伤炎症疾病治疗用组合物
EP3378474B1 (en) Composition for the use in the treatment of plantar hyperhidrosis predisposing to cutaneous fungal infection of the foot
JPH0112725B2 (enExample)
JP2025090529A (ja) チモールエステル系化合物を含む発毛または育毛促進用組成物
JP2025041554A (ja) チモールエステル系化合物を含む皮膚活力増強用組成物
JP2025106164A (ja) チモールエステル系化合物を含む皮膚保護用組成物
JPH10245393A (ja) トリテルペン類を含有する組成物
JPS60243020A (ja) ５α−リダクタ−ゼ阻害剤
JPS6344511A (ja) 養毛剤
JPH0524126B2 (enExample)
JPS6368551A (ja) Ｎ−〔２−ヒドロキシ−２−（４−ヒドロキシフエニル）エチル〕ベンズアミドおよび該化合物を有効成分とする循環器疾患治療剤および皮膚外用剤
JPH0410466B2 (enExample)
HK1220369B (en) Soft anticholinergic esters for the treatment of hyperhidrosis

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)